Skip to main content

Table 4 Univariate and multivariate Cox analysis for overall survival

From: Prognostic and predictive value of interstitial lung abnormalities and EGFR mutation status in patients with non-small cell lung cancer

Variables

Univariate analysis for OS

Multivariate analysis for OS

 

HR (95% CI)

P value

HR (95% CI)

P value

Sex (male vs. female)

3.066 (1.366–6.884)

0.007

1.091 (0.367–3.243)

0.875

Smoking status (current or former smoker vs. never)

2.121 (1.101–4.087)

0.025

1.384 (0.595–3.220)

0.450

ILA subcategory (subpleural fibrotic ILA vs. non-fibrotic ILA)

2.065 (1.156–3.690)

0.014

1.282 (0.678–2.424)

0.444

EGFR status (mutated vs. wild)

0.165 (0.059–0.466)

0.001

0.169 (0.042–0.675)

0.012

TNM staging (III-IV vs. I-II)

16.414 (2.258-119.292)

0.006

14.819 (1.936-113.407)

0.009

Histologic findings (adenocarcinoma vs. non-adenocarcinoma)

0.301 (0.156–0.581)

<0.001

0.612 (0.293–1.281)

0.193

Pleural traction (+)

0.503 (0.285–0.889)

0.018

0.802 (0.428–1.503)

0.491

Pleural fluid (+)

3.740 (2.005–6.977)

<0.001

2.796 (1.347–5.803)

0.006

  1. OS Overall survival, HR Hazard ratio, CI Confidence interval, EGFR Epidermal growth factor receptor, ILA Interstitial lung abnormality